Latest News

Zenith Exports (NSE:ZENITHEXPO) has had a great run on the share market with its stock up by a significant 11% over the...

The quarterly results for Ambuja Cements Limited ( NSE:AMBUJACEM ) were released last week, making it a good time to...

When close to half the companies operating in the Energy Services industry in India have price-to-sales ratios (or...

Suzlon Energy Limited ( NSE:SUZLON ) shareholders might be concerned after seeing the share price drop 22% in the last...

Sun Pharmaceutical Industries Limited ( NSE:SUNPHARMA ) just released its third-quarter report and things are looking...

Ajanta Pharma Limited ( NSE:AJANTPHARM ) just released its latest third-quarter results and things are looking bullish...

Key Insights Significant insider control over HBL Engineering implies vested interests in company growth The largest...

Ideally, your overall portfolio should beat the market average. But even the best stock picker will only win with some...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Key Insights GemLife Communities Group's significant retail investors ownership suggests that the key decisions are...

Key Insights The projected fair value for Oiltek International is S$0.69 based on 2 Stage Free Cash Flow to Equity...

You may think that with a price-to-sales (or "P/S") ratio of 5.8x Shandong Boan Biotechnology Co., Ltd. ( HKG:6955 ) is...

How Tyson Foods' Latest Numbers Fit the Bigger Earnings Story Tyson Foods (TSN) has just reported its Q1 2026 results, with recent quarterly revenue ranging from about US$13.1b to US$13.9b and basic EPS between roughly US$0.02 and US$1.01, while trailing twelve month figures include total revenue of about US$54.4b and EPS of around US$1.33. Over the last few reported quarters, the company has seen revenue move from US$13.6b in Q1 2025 to US$13.9b in Q4 2025, with quarterly EPS shifting from...

Denali Therapeutics recently highlighted past and upcoming presentations of clinical and preclinical data for its Enzyme Transport Vehicle programs in rare lysosomal storage disorders, alongside an ongoing FDA Priority Review of tividenofusp alfa for Hunter syndrome with a decision expected by 5 April 2026. The FDA’s halt of a competing Hunter syndrome gene therapy trial has drawn attention to Denali’s ETV platform as a potential alternative approach for delivering enzyme replacement...

Why the Kayelekera ramp up is drawing attention Lotus Resources (ASX:LOT) is in focus after updating investors on the ramp up of its Kayelekera uranium mine, confirming plans to reach steady state production and first shipments by mid 2026, despite sulphuric acid supply constraints. See our latest analysis for Lotus Resources. Despite a 12.13% one day share price pullback to A$2.68, Lotus still carries a 25.97% 30 day share price return and a 72.62% five year total shareholder return. This...

Doctor Care Anywhere Group PLC ( ASX:DOC ) is possibly approaching a major achievement in its business, so we would...

OpenText (NasdaqGS:OTEX) has appointed Ayman Antoun as Chief Executive Officer. The company has agreed to divest its Vertica business to concentrate on core cloud and AI offerings. These decisions were announced together, signaling a shift in leadership and portfolio focus. OpenText operates in enterprise information management, supplying software that helps large organizations manage content, security, and data across on-premises and cloud environments. The arrival of a new CEO with a...

The Beforepay Group Limited ( ASX:B4P ) share price has fared very poorly over the last month, falling by a substantial...

Key Insights Topsports International Holdings' significant private equity firms ownership suggests that the key...

Twist Bioscience (TWST) opened Q1 2026 with revenue of US$103.7 million and a basic EPS loss of US$0.50, while net income excluding extra items came in at a loss of US$30.5 million. The company reported revenue of US$84.7 million in Q4 2024, US$88.7 million in Q1 2025 and US$103.7 million in Q1 2026. Quarterly basic EPS ranged from a loss of US$0.59 in Q4 2024 to a profit of US$0.34 in Q3 2025 before returning to a loss of US$0.50 in the latest quarter. This keeps the focus on how efficiently...

Key Insights The considerable ownership by retail investors in SOS Lab indicates that they collectively have a greater...

Skyline Bankshares (SLBK) has capped FY 2025 with fourth quarter revenue of US$15.2 million and EPS of US$0.79, set against year over year earnings growth of 97.2% and a trailing net margin of 25.1%. The company has seen revenue move from US$45.6 million to US$57.3 million on a trailing twelve month basis, while EPS over the same span shifted from US$1.34 to US$2.84. This gives investors a clearer line of sight on how profitability is feeding through the income statement. With margins sitting...

While PSK Inc. ( KOSDAQ:319660 ) might not have the largest market cap around , it led the KOSDAQ gainers with a...

Global Payments (NYSE:GPN) agreed to sell its issuer processing business as part of a two step transaction. At the same time, the company plans to acquire Worldpay, a major payments competitor, in a connected deal. The combined moves are described as reshaping Global Payments' core operations and targeting potential synergies for shareholders. For investors watching NYSE:GPN at around $71.99, this deal follows a difficult period for the stock, with a 1 year return of a 34.2% decline and a 5...